BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26079849)

  • 1. Molecular Analysis by Gene Expression of Mitochondrial ATPase Subunits in Papillary Thyroid Cancer: Is ATP5E Transcript a Possible Early Tumor Marker?
    Hurtado-López LM; Fernández-Ramírez F; Martínez-Peñafiel E; Carrillo Ruiz JD; Herrera González NE
    Med Sci Monit; 2015 Jun; 21():1745-51. PubMed ID: 26079849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
    Jiang XL; Zhang H; Chen YL; Peng L
    Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
    [No Abstract]   [Full Text] [Related]  

  • 3. Overexpression of estrogen receptor-α in human papillary thyroid carcinomas studied by laser- capture microdissection and molecular biology.
    Di Vito M; De Santis E; Perrone GA; Mari E; Giordano MC; De Antoni E; Coppola L; Fadda G; Tafani M; Carpi A; Russo MA
    Cancer Sci; 2011 Oct; 102(10):1921-7. PubMed ID: 21707866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of BRAF mutation detection in fine-needle aspiration biopsy samples read as "suspicious for papillary thyroid carcinoma".
    Jara SM; Bhatnagar R; Guan H; Gocke CD; Ali SZ; Tufano RP
    Head Neck; 2015 Dec; 37(12):1788-93. PubMed ID: 24989827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced expression of THRβ in papillary thyroid carcinomas: relationship with BRAF mutation, aggressiveness and miR expression.
    Rosignolo F; Maggisano V; Sponziello M; Celano M; Di Gioia CR; D'Agostino M; Giacomelli L; Verrienti A; Dima M; Pecce V; Durante C
    J Endocrinol Invest; 2015 Dec; 38(12):1283-9. PubMed ID: 26003825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymosin beta 10 correlates with lymph node metastases of papillary thyroid carcinoma.
    Zhang XJ; Su YR; Liu D; Xu DB; Zeng MS; Chen WK
    J Surg Res; 2014 Dec; 192(2):487-93. PubMed ID: 24974154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mRNA BRAF expression helps to identify papillary thyroid carcinomas in thyroid nodules independently of the presence of BRAFV600E mutation.
    Araujo PP; Marcello MA; Tincani AJ; Guilhen AC; Morari EC; Ward LS
    Pathol Res Pract; 2012 Aug; 208(8):489-92. PubMed ID: 22770943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical levels of cyclo-oxygenase-2, matrix metalloproteinase-9 and vascular endothelial growth factor in papillary thyroid carcinoma and their clinicopathological correlations.
    Meng XY; Zhang Q; Li Q; Lin S; Li J
    J Int Med Res; 2014 Jun; 42(3):619-27. PubMed ID: 24670538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DKK3 is a potential tumor suppressor gene in papillary thyroid carcinoma.
    Yin DT; Wu W; Li M; Wang QE; Li H; Wang Y; Tang Y; Xing M
    Endocr Relat Cancer; 2013 Aug; 20(4):507-14. PubMed ID: 23702469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer.
    Lee JC; Zhao JT; Clifton-Bligh RJ; Gill A; Gundara JS; Ip JC; Glover A; Sywak MS; Delbridge LW; Robinson BG; Sidhu SB
    Cancer; 2013 Dec; 119(24):4358-65. PubMed ID: 24301304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of serum DKK-1 predicts poor prognosis in patients with papillary thyroid cancer.
    Zhao YP; Wang W; Wang XH; Xu Y; Wang Y; Dong ZF; Zhang JJ
    Genet Mol Res; 2015 Dec; 14(4):18886-94. PubMed ID: 26782539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer.
    Saiselet M; Gacquer D; Spinette A; Craciun L; Decaussin-Petrucci M; Andry G; Detours V; Maenhaut C
    BMC Genomics; 2015 Oct; 16():828. PubMed ID: 26487287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expressions of miRNAs in papillary thyroid carcinoma and their associations with the clinical characteristics of PTC.
    Hu J; Li C; Liu C; Zhao S; Wang Y; Fu Z
    Cancer Biomark; 2017; 18(1):87-94. PubMed ID: 28085013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma.
    Jung YY; Yoo JH; Park ES; Kim MK; Lee TJ; Cho BY; Chung YJ; Kang KH; Ahn HY; Kim HS
    Pathol Res Pract; 2015 Feb; 211(2):162-70. PubMed ID: 25468810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Runx2 mRNA expression in the tissue, serum, and circulating non-hematopoietic cells of patients with thyroid cancer.
    Dalle Carbonare L; Frigo A; Francia G; Davì MV; Donatelli L; Stranieri C; Brazzarola P; Zatelli MC; Menestrina F; Valenti MT
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1249-56. PubMed ID: 22511796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of long noncoding RNA NONHSAT037832 in papillary thyroid carcinoma and its clinical significance.
    Lan X; Sun W; Zhang P; He L; Dong W; Wang Z; Liu S; Zhang H
    Tumour Biol; 2016 May; 37(5):6117-23. PubMed ID: 26611646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Follicular cell (papillary and follicular) thyroid carcinoma, genetic inheritance, and molecular diagnostic markers].
    Kazubskaia TP; Kozlova VM; Kondrat'eva TT; Pavlovskaia AI; Marakhonov AV; Baranova AV; Ivanova NI; Stepanova AA; Poliakov AV; Belev NF; Brzhezovskiĭ VZh
    Arkh Patol; 2014; 76(5):3-12. PubMed ID: 25543402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dicer expression and microRNA dysregulation associate with aggressive features in thyroid cancer.
    Erler P; Keutgen XM; Crowley MJ; Zetoune T; Kundel A; Kleiman D; Beninato T; Scognamiglio T; Elemento O; Zarnegar R; Fahey TJ
    Surgery; 2014 Dec; 156(6):1342-50; discussion 1350. PubMed ID: 25456905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTEN loss is associated with follicular variant of Middle Eastern papillary thyroid carcinoma.
    Beg S; Siraj AK; Jehan Z; Prabakaran S; Al-Sobhi SS; Al-Dawish M; Al-Dayel F; Al-Kuraya KS
    Br J Cancer; 2015 Jun; 112(12):1938-43. PubMed ID: 25989274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma.
    Zhao H; Zhang ZH; Zhou B; Xiao T; Pan QJ; Guo HQ
    Diagn Cytopathol; 2015 Oct; 43(10):786-90. PubMed ID: 26152656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.